Evaluation of the Level of Lysyle Oxidase and Some Biochemical Parameters in People with Glaucoma
Downloads
The study sought to quantify a few biochemical factors in glaucoma patients' blood serum. A significant increase in the activity of the lysyl oxidase like -4 (LOXL-4) enzyme in patients' blood serum who have gluacoma of both genders was found statistical significance (p≤0.01) in the study, which involved 90 healthy and glaucoma patients (ages 50–83). Additionally, by assessing twelve oxidation and antioxidant variables as well as enzyme activity, it sought to compare the effects of oxidative stress on gluacoma patients to those in good condition. In contrast to those in good health, the findings showed a substantial increase in the activity of the LOXL-4 enzyme, malondialdehyde, lipoxygenase, and (TNF-a) at the p-value (p≤0.01*). Additionally, because of the increased oxidative stress, the data showed that all antioxidants (vit C, vit D, albumin, glutathione, glutathione peroxidase, ceruloplasmin , zinc) were significantly lower in glaucoma patients than in healthy individuals. Gender's impact was also examined.
1. Ball, J., Bewick, V., and Cheek, L. (2004). One-way analysis of variance is covered in Statistics Review 9. 8, 1–7, Critical Care.
2. Adamkewicz, J. I., Smith, V., Lyman, S. K., Chien, J., Li, X., Bornstein, J. D., & Shao, L. (2014). Application for U.S. Patent No. 14/067,740.
3. Aihara, M., Yasunaga, H., Matsui, H., Hashimoto, Y., and Fujita, A. (2023). A retrospective cohort research examining the relationship between lifestyle choices and the incidence of glaucoma. 37(16), 3470-3476; Eye.
4. Heijboer, A. C., Blankenstein, M. A., Kema, I. P., & Buijs, M. M. (2012). Accuracy of 6 routine 25- hydroxyl vitamin D assays: influence of vitamin D binding protein concentration. Clinical chemistry, 58(3), 543-548.
5. Blankenstein, M. A., Heijboer, A. C., Kema, I. P., & Buijs, M. M. (2012). The effect of vitamin D binding protein concentration on the accuracy of six standard 25-hydroxyl vitamin D tests. 543-548 in Clinical Chemistry, 58(3).
6. Ceylan, A., Isik, R., and Isik, B. (2007). Both smokers and non-smokers experience oxidative stress. Toxicology of Inhalation, 19(9), 767-769.
7. Van Zyl, T., and Jacobi, A. (2020). Recent Research Efforts to Achieve Neuroprotection, Progression, and Treatment of Glaucoma [Present Research Efforts to Achieve Neuroprotection, Verlauf, and Treatment of Glaucoma]. 133–139 in Klinische Monatsblatter für Augenheilkunde, 237(2). 1055/a-1079-5778 https://doi.org
8. Abdull, M. M., Jain, M., Jain, V., and Bastawrous, A. (2017). A comprehensive evaluation of the relationship between smoking cigarettes and primary open-angle glaucoma. 37, 291-301; International Ophthalmology.
9. Töteberg-Harms, M., and I. Krzyzanowska (2022). Winkelblockglaukome [glaucoma with angle closure]. 1167–1179 in Die Ophthalmologie, 119(11). The article https://doi.org/10.1007/s00347-022-01745-w
10. George, R. J., Shantha, B., Vijaya, L., Sulochana, K. N., Coral, K., & NikhalaShree, S. (2023). A correlation between clinical indices and copper, lysyl oxidase activity, and collagen in the aqueous humor of primary glaucoma. 949–957 in Ophthalmic Research, 66(1)
11. Sauberlich, H. E., Turnbull, J. D., and Omaye, S. T. (1979). [1] Ascorbic acid levels in animal cells, tissues, and fluids may be determined using specific techniques. In Enzymology Methods (Vol. 62, pp. 3-11). Scholarly press
12. Patel, P., Belamkar, A., Harris, A., Toris, C., Tobe, L., Lang, M., & Siesky, B. (2018). Sex hormones' effects on intraocular pressure and ocular blood flow in primary open-angle glaucoma: a review. 1037–1041, Journal of Glaucoma, 27(12). ????
13. Martínez-González, M. Á., Martín-Calvo, N., Fernández-Montero, A., Pérez-de-Arcelus, M., Toledo, E., & Moreno-Montañés, J. (2017). The SUN Cohort: Smoking and the prevalence of glaucoma. Medicine, 96(1), e5761. 10.1097/MD.0000000000005761 https://doi.org
14. Virgili, G., Breda, J. B., Cutolo, C. A., Michelessi, M., Qureshi, R., Azuara-Blanco, A., Michelessi, M., & Li, T. (2021). An analysis of systematic reviews reveals what we really know about the efficacy of glaucoma therapies. Glaucoma in Ophthalmology, 4(5), 454-462
15. Rosell-Garcia, T., and Rodriguez-Pascual, F. (2022). The difficulty of measuring lysyl oxidase activity: traditional techniques and new strategies. 639, 114508; Analytical Biochemistry. Lindsay, R. H., and Sedlak, J. (1968). Ellman's reagent is used to estimate the number of total, protein-bound, and nonprotein sulfhydryl groups in tissue. 25, 192–205; Analytical Biochemistry.
16. Zhang, C., Chan, Y. T., Yuen, M. F., Tan, H. Y., Wang, N., & Feng, Y. (2021). During hepatocarcinogenesis, lysyl oxidase-like 4 promotes an immunosuppressive microenvironment. 2326-2341 in Hepatology, 73(6).
17. N.W. Tietz, "Fundamentals of Clinical Chemistry," 2nd ed., W.B. Saunders Company, U.S.A., 302, 337, 539, 901
18. P. C. Trackman (2022). Disease processes and the biology of lysyl oxidase. 20–37 in Matrix Biology, 114. 10.1016/j.matbio.2022.03.003 | https://doi.org
19. Vergroesen, J. E., Cousins, C. C., Hysi, P. G., Stuart, K. V., de Vries, V., Tran, J. H., & International Glaucoma Genetics Consortium. (2023). Genetic links between smoking and characteristics associated with glaucoma. Science & Technology of Translational Vision, 12(2), 20–20.
20. Fink, B. A., Zadnik, K., & Wagner, H. (2008). Disparities between healthy and sick eyes by sex and gender. American Optometric Association Journal of Optometry, 79(11), 636–652.
21. Huang, J., Xie, Z., Chen, X., Zheng, Z., Wang, J., Chen, C., Huang, J., Xie, Z., etc. & Zou, H. (2023). The potential of LOXL4 as a cancer prognostic marker. 1519–1529 in Amino Acids, 55(11).
22. Guo, Y., Zhang, Y., Huang, S., Zhong, Y., & Wang, Y. (2024). The distinctions and similarities between primary angle-closure glaucoma and primary open angle glaucoma. 16–54; Eye and Brain. The article https://doi.org/10.2147/EB.S472920
23. Mobarhan, M. G., Hassanzadeh, S., Zarei-Ghanavati, S., Yahaghi, B., Hakimi, H. R., & Eghbali, P. (2020). Copper, zinc, selenium, and serum 25-hydroxyvitamin D in keratoconus patients. Current Ophthalmology Journal, 32(1), 26–31
